Ascendis Pharma A (ASND) Cash from Discontinued Operations (2021 - 2025)
Ascendis Pharma A (ASND) reported Cash from Discontinued Operations of 68137206.94 for Q3 2025, up 210.53% on a YoY basis from 21942010.18 in Q3 2024, and up 210.53% sequentially from 61644158.9 in Q3 2024.
Ascendis Pharma A (ASND) Cash from Discontinued Operations (2021 - 2025) Analysis & Trends
Ascendis Pharma A (ASND) has 5 years of Cash from Discontinued Operations data on file, last reported at 68137206.94 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 68.14 Mn |
| Sep 30, 2025 | 68.14 Mn |
| Sep 30, 2024 | -61.64 Mn |
| Sep 30, 2024 | -61.64 Mn |
| Jun 30, 2023 | -166.74 Mn |
| Jun 30, 2023 | -166.74 Mn |
| Mar 31, 2023 | -157.83 Mn |
| Mar 31, 2023 | -157.83 Mn |
| Sep 30, 2022 | -99.65 Mn |
| Sep 30, 2022 | -99.65 Mn |
| Jun 30, 2022 | -132.73 Mn |
| Jun 30, 2022 | -132.73 Mn |
| Mar 31, 2022 | -146.79 Mn |
| Mar 31, 2022 | -146.79 Mn |
| Sep 30, 2021 | -115.00 Mn |
| Sep 30, 2021 | -115.00 Mn |
| Jun 30, 2021 | -138.73 Mn |
| Jun 30, 2021 | -138.73 Mn |
| Mar 31, 2021 | -98.45 Mn |
| Mar 31, 2021 | -98.45 Mn |